Results 21 to 30 of about 41,836 (256)

Retracted: A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation. [PDF]

Biomed Res Int
International BR.
europepmc   +3 more sources

Arginine vasopressin 2 receptor (AVPR2; V2R); prostaglandin E2 receptor EP4 subtype (prostanoid EP4 receptor; PTGER4) [PDF]

Science-Business eXchange, 2009

openalex   +2 more sources

In silico study on the internal signal pathway of different mutants of vasopressin receptor 2 with arginine vasopressin bound [PDF]

Biophysical Journal, 2023
Ting-Yu Hu, Hao‐Jen Hsu, Chun‐Chun Chang   +2 more
openalex   +2 more sources

SP011CHARACTERIZATION OF NOVEL MUTATIONS IN ARGININE VASOPRESSIN RECEPTOR 2 GENE (AVRP2) CAUSING NEPHROGENIC DIABETES INSIPIDUS [PDF]

Nephrology Dialysis Transplantation, 2018
F Prosperi, Vincenzo Costanzo, Anna Iervolino, Federica Petrillo, Luigi De la Motte, Pierluigi Marzuillo, Sabina Jeleń, Angela La Manna, Giovambattista Capasso, Francesco Trepiccione   +9 more
openalex   +2 more sources

Zhenwu decoction ameliorates adriamycin-induced nephrotic syndrome in rats via dual modulation of AVP-V2R-AQP2 and RAAS-MR-AQP3 pathways [PDF]

Renal Failure
The core bioactive components of Zhenwu Decoction (ZWD)—utilized for managing kidney diseases—and the associated anti-nephrotic syndrome (NS) edema mechanism remain incompletely characterized. We assessed the potential mechanism of ZWD against adriamycin
Mengmeng Xu, Min Du, Wanying Qu, Yanjun Wei, Hui Wang, Xin Yang   +5 more
doaj   +2 more sources

A Novel Mutation in the Arginine Vasopressin Receptor 2 Gene Causing Congenital Nephrogenic Diabetes Insipidus

Journal of Clinical Research in Pediatric Endocrinology, 2018
Aslı Çelebi Tayfur, Tuğçe Karaduman, Merve Özcan Türkmen, Dilara Şahin, Aysun Çaltık Yılmaz, Bahar Büyükkaragöz, Ayşe Derya Buluş, Hatice Mergen   +7 more
openalex   +2 more sources

Arginine-vasopressin analogs with high antidiuretic/vasopressor selectivity. Synthesis, biological activity and receptor binding affinity of arginine-vasopressin analogs with substitutions in positions 1, 2, 4, 7, and 8

Journal of Medicinal Chemistry, 1986
In a search for more selective agonists of arginine-vasopressin (AVP), 10 analogues of [Sar7]- and [MeLa7]AVP with additional substitutions in positions 1 (beta-mercaptopropionic acid), 2 (phenylalanine), 4 (valine), or 8 (D-arginine) were synthesized and tested for antidiuretic and vasopressor activities.
Zbigniew Grzonka, Franciszek Kasprzykowski, Elżbieta Kojro, Krzysztof Darłak, Per Melin, Falk Fahrenholz, Peter Crause, Rainer Boer   +7 more
  +6 more sources

Arginine vasopressin increases glutamate release and intracellular Ca²⁺concentration in hippocampal and cortical astrocytes through two distinct receptors [PDF]

Journal of Neurochemistry, 2007
AbstractArginine vasopressin (AVP), released from the CNS, plays an important role in regulating several aspects of CNS functions including aggression, anxiety, and cognition. In this study, we report a novel finding that AVP induces glutamate release from astrocytes isolated from the cerebral cortex and hippocampus.
Nasser Syed, Catherine A. Martens, Walter H. Hsu   +2 more
openalex   +3 more sources

Agonist of V 2 vasopressin receptor, 1-dezamino-8-D-arginine-vasopressin, reduces parkinson's disease symptoms

Reviews on Clinical Pharmacology and Drug Therapy, 2013
In clinical trials have studied one of the central effects of a selective agonist of V 2 vasopressin receptors, 1-dezamino-8-D-arginine-vasopressin (DDAVP), in patients with Parkinson's disease (PD) and parkinsonism. In patients with a tremor-rigid shape and akinetic-rigid form of the disease regressed major movement disorders: tremor,
Svetlana G. Belokoskova, Sergey Georgiyevich Tsikunov   +1 more
openalex   +3 more sources

Effects of vasopressin receptor agonists on detrusor smooth muscle tone in young and aged bladders: Implications for nocturia treatment

Continence, 2022
Purpose:: The main goal of this study was to determine the effects of arginine vasopressin (AVP) and desmopressin on bladder contractility and to examine whether the effects of these vasopressin receptor (VR) agonists differ in young versus aged animals.
Youko Ikeda, Irina Zabbarova, Mathijs de Rijk, Anthony Kanai, Amanda Wolf-Johnston, Jeffrey P. Weiss, Edwin Jackson, Lori Birder   +7 more
doaj   +1 more source